"The said batches have successfully passed all the checks for quality parameters both at the Gamaleya Center in Russia and at the Central Drug Laboratory, Kasauli, Himachal Pradesh in India," Panacea told stock exchanges on July 5.from Moneycontrol Business News https://ift.tt/3ApNVdU
No comments:
Post a Comment